drugset / Trial / NCT05426161

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities

NCT05426161 ↗

Phase 4 Completed 10 enrolled Bispebjerg Hospital
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to investigate the effect of subcutaneous administration of Botulinum toxin A on wound pain, wound healing and safety of treatment.

Timeline

Start
2023-02-07
Primary completion
2024-04-23
Completion
2024-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 unknown Subcutaneous